| Literature DB >> 30294193 |
Piotr Kawczak1, Leszek Bober2, Tomasz Bączek1,3.
Abstract
A set of psychoactive drugs has been analyzed with the use of quantitative structure-activity/property relationships methods. The purpose of this study was to demonstrate both the common and differentiating characteristics of the above-mentioned chemical compounds, physicochemical as well as pharmacological based on the quantum chemical calculations and selected biological activity data and chromatographic retention parameters. During the study, the ab initio model of molecular modeling was performed and PCA, FA, and MLR as the types of chemometric approach. QSAR/QSPR models were proposed based on chosen statistically significant descriptors. The relationship between the structure and biological activity data was able to class and describe the psychoactive properties of the molecules studied. The applied chemometric approaches revealed the influential features of tested structures responsible for their pharmacological activity together with some additional physicochemical properties.Entities:
Keywords: Descriptors; Molecular modeling; Psychoactive drugs; QSAR; QSPR; Structural analysis
Year: 2018 PMID: 30294193 PMCID: PMC6154038 DOI: 10.1007/s00044-018-2234-5
Source DB: PubMed Journal: Med Chem Res ISSN: 1054-2523 Impact factor: 1.965
Figure 1Structural formulas of compounds studied
The numerical values of 10 structural parameters derived from Gaussian quantum-chemical calculations for all 25 compounds studied
| Compound | TE | ESE | E_HOMO | E_LUMO | EG | MAX_POS | MAX_NEG | Δ | TDM | IPOL |
|---|---|---|---|---|---|---|---|---|---|---|
| Aceperon | −1283.84 | 21234.30 | −8.9739 | 2.5415 | 11.5154 | 0.7254 | −0.7283 | 1.4537 | 6.3837 | 242.90 |
| Acetophenazine | −1598.45 | 14981.03 | −7.6523 | 2.3717 | 10.0240 | 0.5402 | −0.7950 | 1.3352 | 1.7719 | 259.79 |
| Amitriptiline | −825.22 | 6515.35 | −8.1413 | 3.5380 | 11.6793 | 0.1801 | −0.5770 | 0.7571 | 1.1089 | 199.06 |
| Benperidol | −1259.67 | 20740.83 | −7.9418 | 2.6286 | 10.5704 | 1.0460 | −0.8566 | 1.9026 | 3.1622 | 228.43 |
| Chlorpromazine | −1620.72 | 8397.08 | −7.7290 | 3.2460 | 10.9750 | 0.3143 | −0.7846 | 1.0989 | 2.7007 | 201.34 |
| Chlorprothixene | −1603.56 | 8999.30 | −7.9483 | 2.6438 | 10.5921 | 0.2668 | −0.5915 | 0.8583 | 2.2333 | 211.05 |
| Clomipramine | −1301.28 | 8666.11 | −8.0945 | 3.5056 | 11.6001 | 0.2790 | −0.7897 | 1.0687 | 2.7070 | 204.08 |
| Desipramine | −803.36 | 6526.89 | −7.8879 | 3.7848 | 11.6727 | 0.2804 | −0.7888 | 1.0692 | 0.9264 | 183.15 |
| Dixyrazine | −1638.63 | 18634.72 | −7.5078 | 3.5674 | 11.0752 | 0.3471 | −0.8013 | 1.1484 | 1.4385 | 269.39 |
| Droperidol | −1258.48 | 19155.09 | −7.9960 | 2.5135 | 10.5095 | 1.0333 | −0.8941 | 1.9274 | 5.3046 | 225.82 |
| Fluphenazine | −1782.30 | 16638.00 | −7.7804 | 2.9826 | 10.7630 | 1.1718 | −0.7955 | 1.9673 | 4.7537 | 246.12 |
| Haloperidol | −1571.75 | 17976.49 | −8.7881 | 2.4400 | 11.2281 | 0.5509 | −0.6697 | 1.2207 | 3.9820 | 220.16 |
| Imipramine | −842.38 | 7331.05 | −7.8795 | 3.7897 | 11.6692 | 0.2800 | −0.7892 | 1.0693 | 0.7071 | 193.13 |
| Levomepromazine | −1314.75 | 8340.75 | −7.3870 | 3.6136 | 11.0006 | 0.4185 | −0.8025 | 1.2209 | 1.5158 | 215.72 |
| Nortriptiline | −786.19 | 6148.49 | −8.0906 | 3.5102 | 11.6008 | 0.2710 | −0.6326 | 0.9036 | 1.6374 | 189.70 |
| Perphenazine | −1905.57 | 14014.45 | −7.6751 | 3.2868 | 10.9619 | 0.3607 | −0.7944 | 1.1551 | 3.8012 | 246.35 |
| Prochlorperazine | −1791.68 | 11122.23 | −7.6588 | 3.2955 | 10.9543 | 0.3613 | −0.7944 | 1.1557 | 2.0514 | 233.31 |
| Promazine | −1161.82 | 7343.41 | −7.1788 | 3.5344 | 10.7132 | 0.3786 | −0.8293 | 1.2078 | 2.5886 | 193.37 |
| Promethazine | −1161.82 | 5419.31 | −7.2528 | 3.6487 | 10.9015 | 0.3699 | −0.8095 | 1.1793 | 2.1065 | 187.65 |
| Spiroperidol | −1298.66 | 20148.70 | −8.6112 | 2.6278 | 11.2390 | 0.7960 | −0.7296 | 1.5256 | 4.3300 | 234.58 |
| Thioproperazine | −2013.05 | 14948.37 | −7.8264 | 2.6357 | 10.4621 | 1.7000 | −0.7947 | 2.4947 | 5.9427 | 270.47 |
| Thioridazine | −1714.32 | 10820.72 | −7.6270 | 3.0993 | 10.7263 | 0.3470 | −0.7869 | 1.1339 | 2.6694 | 247.11 |
| Trifluoperazine | −1668.40 | 12802.53 | −7.7701 | 2.9804 | 10.7505 | 1.1715 | −0.7956 | 1.9672 | 2.5362 | 232.44 |
| Trifluopromazine | −1497.44 | 10070.78 | −7.8596 | 2.9567 | 10.8163 | 1.1740 | −0.7842 | 1.9583 | 3.3624 | 200.41 |
| Triperidol | −1448.48 | 21739.60 | −8.8887 | 2.4065 | 11.2952 | 1.1740 | −0.6691 | 1.8432 | 4.7615 | 219.02 |
Chromatographic parameter values of selected antipsychoctic drugs
| Compound | log kAGP | log kIAM | log kw2.5Su | log kw7.4Su | log kw2.5Sp | log kw7.0Sp | log kw7.3Al | log kw11.7Un |
|---|---|---|---|---|---|---|---|---|
| Chlorpromazine | 2.131 | 1.435 | 1.595 | 4.051 | 1.935 | 2.632 | 3.309 | 4.076 |
| Chlorprothixene | 2.206 | 1.533 | 1.597 | 4.642 | 2.244 | 2.417 | 4.440 | 4.235 |
| Clomipramine | 2.005 | 1.391 | 0.781 | 4.144 | 2.353 | 2.473 | 4.115 | 3.910 |
| Desipramine | 1.595 | 1.031 | 2.134 | 3.020 | 2.015 | 2.341 | 3.171 | 2.888 |
| Fluphenazine | 2.159 | 1.496 | 1.683 | 4.554 | 2.922 | 2.688 | 4.067 | 3.352 |
| Imipramine | 1.670 | 1.097 | 1.391 | 3.535 | 2.082 | 3.158 | 3.133 | 3.020 |
| Perphenazine | 2.283 | 1.393 | 1.635 | 4.305 | 2.997 | 3.092 | 3.256 | 3.070 |
| Prochlorperazine | 2.614 | 1.726 | 1.452 | 4.878 | 1.843 | 2.421 | 4.395 | 3.523 |
| Promazine | 1.890 | 1.165 | 1.556 | 3.492 | 2.338 | 2.808 | 3.794 | 3.294 |
| Promethazine | 1.833 | 1.508 | 1.693 | 4.081 | 1.132 | 3.169 | 3.069 | 3.216 |
| Thioridazine | 2.448 | 1.752 | 2.113 | 4.260 | 2.055 | 2.924 | 3.182 | 4.635 |
| Trifluoperazine | 2.388 | 1.820 | 1.778 | 4.948 | 1.792 | 2.644 | 5.022 | 3.632 |
| Triflupromazine | 1.976 | 1.514 | 1.960 | 4.409 | 2.533 | 2.638 | 3.790 | 4.117 |
Biological activity/physicochemical properties values of selected antipsychotic drugs
| Compound | −Δ | log 1/D | log (1/ED50 × 10−3) | log ATPase activity |
|---|---|---|---|---|
| Aceperon | 0.37 | −1.623 | — | — |
| Acetophenazine | — | — | 2.12 | — |
| Amitriptiline | — | — | 1.85 | — |
| Benperidol | 1.82 | 1.523 | — | — |
| Chlorpromazine | 5.12 | −0.301 | 2.52 | −0.21 |
| Chlorprothixene | 0.19 | 0.022 | 2.57 | — |
| Clomipramine | — | — | 2.22 | — |
| Desipramine | — | — | 1.58 | — |
| Dixyrazine | 4.78 | −0.398 | — | — |
| Droperidol | 0.96 | 1.284 | — | — |
| Fluphenazine | 0.00 | 1.097 | — | — |
| Haloperidol | 5.16 | 1.284 | — | — |
| Imipramine | — | — | 1.79 | −0.99 |
| Levomepromazine | 3.42 | −0.330 | — | — |
| Nortriptiline | — | — | 1.76 | — |
| Perphenazine | — | — | 2.63 | 0.09 |
| Prochlorperazine | 0.00 | 0.137 | 2.75 | 0.87 |
| Promazine | — | — | 2.05 | −1.17 |
| Promethazine | — | — | 1.82 | −0.37 |
| Spiroperidol | 0.69 | 2.000 | — | — |
| Thioproperazine | 0.00 | 0.602 | — | — |
| Thioridazine | — | — | 2.72 | 0.79 |
| Trifluoperazine | — | — | 2.92 | 1.69 |
| Trifluopromazine | — | — | — | 0.27 |
| Triperidol | 5.78 | 1.456 | — | — |
Figure 2Three-dimensional scatter plots of the scores derived from the quantum-chemical calculations of structural parameters of the first three components obtained using PCA (PC1 50.21%, PC2 22.63%, PC3 10.89%) together with two-dimensional plot of scores the first two factors obtained by FA (FA1 50.21%, FA2 22.63%)
List of statistically significant molecular descriptors characterizing biological activity/physicochemical properties/chromatographic retention obtained from Dragon software (Eqs. 9–18)
| Descriptor | Full name | Block |
|---|---|---|
| Biological activity/physicochemical properties | ||
| CATS2D_09_DA | CATS (Chemically Advanced Template Search) 2D Donor–Acceptor at lag 09 | CATS2D |
| RDF095v | Radial Distribution Function - 095 / weighted by van der Waals volume | RDF descriptors |
| H4m | H autocorrelation of lag 4/weighted by mass | GETAWAY (GEometry, Topology, and Atom-Weights AssemblY) descriptors |
| H-053 | H attached to C0(sp3) with 2X attached to next C | Atom-centered fragments |
| PJI3 | 3D Petitjean shape index | Geometrical descriptors |
| AVS_B(e) | Average vertex sum from Burden matrix weighted by Sanderson electronegativity | 2D matrix-based descriptors |
| DISPm | Displacement value/weighted by mass | Geometrical descriptors |
| Mor08u | Signal 08/unweighted | 3D-MoRSE (3D-Molecule Representation of Structures based on Electron diffraction) descriptors |
| MATS6s | Moran autocorrelation of lag 6 weighted by I-state | 2D autocorrelations |
| Eig04_AEA(bo) | eigenvalue n. 4 from augmented edge adjacency mat. weighted by bond order | Edge adjacency indices |
| GATS5s | Geary autocorrelation of lag 5 weighted by I-state | 2D autocorrelations |
| Retention parameters | ||
| H1v | H autocorrelation of lag 1/weighted by van der Waals volume | GETAWAY descriptors |
| DISPi | Displacement value/weighted by ionization potential | Geometrical descriptors |
| H2u | H autocorrelation of lag 2/unweighted | GETAWAY descriptors |
| X1A | Average connectivity index of order 1 | Connectivity indices |
| GATS5m | Geary autocorrelation of lag 5 weighted by mass | 2D autocorrelations |
| Mor06p | Signal 06/weighted by polarizability | 3D-MoRSE descriptors |
| R2v | R autocorrelation of lag 2/weighted by van der Waals volume | GETAWAY descriptors |
| CMC-50 | Ghose–Viswanadhan–Wendoloski CMC drug-like index at 50% | Drug-like indices |
| R1e+ | R maximal autocorrelation of lag 1/weighted by Sanderson electronegativity | GETAWAY descriptors |
| Mor09i | Signal 09/weighted by ionization potentia | 3D-MoRSE descriptors |
| B08[C-N] | Presence/absence of C-N at topological distance 8 | 2D Atom Pairs |
| H6m | H autocorrelation of lag 6/weighted by mass | GETAWAY descriptors |
| ATS6s | Broto–Moreau autocorrelation of lag 6 (log function) weighted by I-state | 2D autocorrelations |
| H4i | H autocorrelation of lag 4/weighted by ionization potential | GETAWAY descriptors |
| ALOGP2 | Squared Ghose–Crippen octanol-water partition coeff. (logP^2) | Molecular properties |
| HATS1v | Leverage-weighted autocorrelation of lag 1/weighted by van der Waals volume | GETAWAY descriptors |
| R8v | R autocorrelation of lag 8/weighted by van der Waals volume | GETAWAY descriptors |